None

  3. About Novo Nordisk

    Novo Nordisk (CSE1158|NOVO B, NVO) manufactures and markets pharmaceutical products and services. Founded in Denmark in 1923, it is one of the world's leading companies in diabetes care, including the products within the area of insulin delivery systems. Novo Nordisk also has a leading position in haemostasis management, growth hormone therapy and hormone replacement therapy.

    With headquarters in Denmark, Novo Nordisk has production facilities in six countries, with affiliates or offices in 68 countries. Novo Nordisk employs 23,172 people globally (as of 2006) [http://finance.google.com/finance?q=NVO&hl;=en].

    Novo Nordisk is dedicated to developing its business towards ecological, social and economic sustainability. The company says this commitment is demonstrated through its values and its environmental and social responsibility policies also called the "triple bottom-line".Novo Nordisk founded the World Diabetes foundation to save the lives of those affected by diabetes in developing countries and were instrumental in achieving a UN resolution to fight diabetes. Making diabetes the only other disease alongside HIV AIDs to have a commintment to combat at a UN level. Such is diabetes present and future danger to human health on a global scale.

  1. Novo Nordisk

    0 Comments Leave a Comment

    1-4 of 4

    1. Mentioned In 4 Articles

    2. web internet marketing- Learn as You Go Writing

      Explore Learn as You Go Writing (Jun 22 2010)

      ... Pfizer; Daiichi Sankyo; Acorda Therapeutics; Novartis Diagnostics; Sanofi-Aventis Pharmaceuticals; Novo Nordisk; Lundbeck; Fleishman-Hillard Digital; Porter Novelli; National Organization for Rare Disorders; Saa... (Read Full Article)

      Mentions:   Washington   Cisco   Microsoft

    3. Media Channel 2.0 — Blog — web internet marketing

      Explore Media Channel 2.0 — Home (Jun 6 2010)

      Media Channel 2.0 — Blog — web internet marketing ...er; Daiichi Sankyo; Acorda Therapeutics; Novartis Diagnostics; Sanofi-Aventis Pharmaceuticals; Novo Nordisk; Lundbeck; Fleishman-Hillard Digital; Porter Novelli; National Organization for Rare Disorders; S... (Read Full Article)

      Mentions:   Intel   Washington   Cisco

    4. Mashable's Weekly Guide to Social Media and Internet Events | Vc ...

      Explore VC Web Marketing (May 24 2010)

      ... Pfizer; Daiichi Sankyo; Acorda Therapeutics; Novartis Diagnostics; Sanofi-Aventis Pharmaceuticals; Novo Nordisk; Lundbeck; Fleishman-Hillard Digital; Porter Novelli; National Organization for Rare Disorders; Saa... (Read Full Article)

      Mentions:   Intel   Washington   Cisco

    5. Mashable: Latest 28 News Updates - including “Large Hadron ...

      Explore Daily News Blog (Mar 31 2010)

      Mashable: Latest 28 News Updates - including “Large Hadron ... ... Pfizer; Daiichi Sankyo; Acorda Therapeutics; Novartis Diagnostics; Sanofi-Aventis Pharmaceuticals; Novo Nordisk; Lundbeck; Fleishman-Hillard Digital; Porter Novelli; National Organization for Rare Disorders; Saa... (Read Full Article)

      Mentions:   Intel   Chris Brogan   Seattle

    6. 1-4 of 4